ConductScience.org, home

Trial · NCT04735432

Results by group139

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percent Change From Baseline in Total IgG Levels at Day 29 (mITT Analysis Set)Efgartigimod PH20 SC-66.495% Confidence Interval -68.91 to -63.86percent
Percent Change From Baseline in Total IgG Levels at Day 29 (mITT Analysis Set)Efgartigimod IV-62.295% Confidence Interval -64.67 to -59.72percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 1-40.1Standard Error 1.45percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 1-39.6Standard Error 1.51percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 2-56.9Standard Error 1.57percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 2-55.1Standard Error 1.85percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 3-62.2Standard Error 1.41percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 3-59Standard Error 2percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 4-64.7Standard Error 1.95percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 4-62.3Standard Error 1.24percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 5-57.4Standard Error 1.7percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 5-49.9Standard Error 2.17percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 6-44Standard Error 2.52percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 6-38.9Standard Error 2.24percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 7-31.2Standard Error 4.67percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 7-25.3Standard Error 2.78percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 8-8.9Standard Error 8.65percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 8-14.6Standard Error 3.13percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod PH20 SCWeek 107.8Standard Error 7.78percent
Percent Change From Baseline in Total IgG Levels Over Time (mITT Analysis Set)Efgartigimod IVWeek 10-3.1Standard Error 3.82percent

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04735432/results